A detailed history of Vantage Consulting Group Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Vantage Consulting Group Inc holds 1,605 shares of JNJ stock, worth $264,536. This represents 0.38% of its overall portfolio holdings.

Number of Shares
1,605
Previous 1,490 7.72%
Holding current value
$264,536
Previous $235,000 0.43%
% of portfolio
0.38%
Previous 0.35%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $16,603 - $18,144
115 Added 7.72%
1,605 $234,000
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $3,880 - $4,068
-25 Reduced 1.65%
1,490 $235,000
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $10,046 - $10,962
69 Added 4.77%
1,515 $237,000
Q3 2023

Nov 14, 2023

BUY
$155.75 - $174.48 $778 - $872
5 Added 0.35%
1,446 $225,000
Q2 2023

Aug 11, 2023

SELL
$154.35 - $166.11 $21,145 - $22,757
-137 Reduced 8.68%
1,441 $238,000
Q1 2023

May 10, 2023

BUY
$151.05 - $180.26 $29,907 - $35,691
198 Added 14.35%
1,578 $244,000
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $27,714 - $31,103
-173 Reduced 11.14%
1,380 $243,000
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $25,167 - $28,005
156 Added 11.17%
1,553 $254,000
Q2 2022

Aug 09, 2022

BUY
$168.19 - $186.01 $7,400 - $8,184
44 Added 3.25%
1,397 $248,000
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $34,158 - $38,791
-216 Reduced 13.77%
1,353 $240,000
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $17,152 - $19,031
110 Added 7.54%
1,569 $268,000
Q3 2021

Nov 10, 2021

BUY
$161.5 - $179.47 $14,373 - $15,972
89 Added 6.5%
1,459 $236,000
Q2 2021

Aug 11, 2021

BUY
$159.48 - $171.07 $218,487 - $234,365
1,370 New
1,370 $226,000
Q1 2021

May 14, 2021

SELL
$153.07 - $170.48 $165,315 - $184,118
-1,080 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $148,078 - $169,970
1,080 New
1,080 $170,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Vantage Consulting Group Inc Portfolio

Follow Vantage Consulting Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Consulting Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vantage Consulting Group Inc with notifications on news.